So your patients can see if it is right for them.*
Eligible patients can pay $0 co-pay up to the program maximum towards out-of-pocket costs associated with IDELVION therapy.†
To help people continue to receive IDELVION if they have a lapse in insurance coverage.‡
Patients can have one-on-one conversations with advocates about hemophilia B, product experience, and other topics.
Find information, including coding and reimbursement guidance.
For patients without insurance or who can’t afford treatment.
*Because dosing is based on various patient traits (eg, weight, Factor IX levels), there may be a cap to the trial. Terms and conditions apply.
†Subject to terms and conditions of the co-pay assistance program. To read the full terms and conditions, visit cslbehring.com/patients/support-and-assistance. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.
‡Terms, conditions, and limitations apply. Visit here to view terms and conditions.
Reference: 1. Data on file Available from CSL Behring as DOF IDL-009.